{"generic":"Typhoid Vaccine, Live","drugs":["Typhoid Vaccine, Live","Vivotif"],"mono":{"0":{"id":"jw2os0","title":"Generic Names","mono":"Typhoid Vaccine, Live"},"1":{"id":"jw2os1","title":"Dosing and Indications","sub":{"0":{"id":"jw2os1b4","title":"Adult Dosing","mono":"<b>Typhoid fever; Prophylaxis:<\/b> 1 capsule ORALLY x 4 doses, on days 1, 3, 5, and 7, to be completed at least one week prior to potential exposure; booster dose (4-capsule course) every 5 years if re-exposure expected (same schedule) "},"1":{"id":"jw2os1b5","title":"Pediatric Dosing","mono":"<ul><li>safety and efficacy have not been established in children less than 6 years of age<\/li><li><b>Typhoid fever; Prophylaxis:<\/b> 6 years and older, 1 capsule ORALLY x 4 doses, on days 1, 3, 5, and 7, to be completed at least one week prior to potential exposure; booster dose (4-capsule course) every 5 years if re-exposure expected (same schedule)<\/li><\/ul>"},"3":{"id":"jw2os1b7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><br\/>Typhoid fever; Prophylaxis<br\/>"}}},"3":{"id":"jw2os3","title":"Contraindications\/Warnings","sub":[{"id":"jw2os3b9","title":"Contraindications","mono":"<ul><li>acute febrile illness<\/li><li>deficiency in ability to produce a humoral or cell-mediated immune response (either congenital or acquired immunodeficiency including treatment with immunosuppressive or antimitotic drugs); safety not demonstrated<\/li><li>hypersensitivity to any component of the vaccine or the enteric-coated capsule<\/li><\/ul>"},{"id":"jw2os3b10","title":"Precautions","mono":"<ul><li>concomitant use with sulfonamides and antibiotics; may prevent induction of a protective immune response<\/li><li>concomitant use with proguanil when used as a single agent (not available in the United States); administer proguanil only if at least 10 days have elapsed since administering the final dose of live typhoid vaccine<\/li><li>continue to take precautions against exposure to typhoid organisms (ie, avoid contact or ingestion of potentially contaminated food or water); vaccine protection is not universal<\/li><li>gastrointestinal illness, acute; vaccination not recommended<\/li><li>persistent diarrhea or vomiting; postpone taking vaccine<\/li><li>to report adverse events, contact the Vaccine Adverse Event Reporting system at 1-800-822-7967<\/li><\/ul>"},{"id":"jw2os3b11","title":"Pregnancy Category","mono":"<ul><li>C (FDA)<\/li><li>B2 (AUS)<\/li><\/ul>"},{"id":"jw2os3b12","title":"Breast Feeding","mono":"<ul><li>WHO: Compatible with breastfeeding.<\/li><li>Micromedex: Infant risk is minimal.<\/li><\/ul>"}]},"4":{"id":"jw2os4","title":"Drug Interactions","sub":{"1":{"id":"jw2os4b14","title":"Major","mono":"<ul><li>Aclarubicin (established)<\/li><li>Adalimumab (theoretical)<\/li><li>Aldesleukin (established)<\/li><li>Altretamine (established)<\/li><li>Amonafide (established)<\/li><li>Amsacrine (established)<\/li><li>Asparaginase (established)<\/li><li>Azacitidine (established)<\/li><li>Azathioprine (established)<\/li><li>Bleomycin (established)<\/li><li>Broxuridine (established)<\/li><li>Busulfan (established)<\/li><li>Capecitabine (established)<\/li><li>Carboplatin (established)<\/li><li>Carmustine (established)<\/li><li>Certolizumab Pegol (theoretical)<\/li><li>Chlorambucil (established)<\/li><li>Cisplatin (established)<\/li><li>Cladribine (established)<\/li><li>Cyclophosphamide (established)<\/li><li>Cyclosporine (theoretical)<\/li><li>Cytarabine (established)<\/li><li>Cytarabine Liposome (established)<\/li><li>Dacarbazine (established)<\/li><li>Dactinomycin (established)<\/li><li>Daunorubicin (established)<\/li><li>Daunorubicin Citrate Liposome (established)<\/li><li>Decitabine (established)<\/li><li>Docetaxel (established)<\/li><li>Doxifluridine (established)<\/li><li>Doxorubicin (established)<\/li><li>Doxorubicin Hydrochloride Liposome (established)<\/li><li>Edatrexate (established)<\/li><li>Eflornithine (established)<\/li><li>Epirubicin (established)<\/li><li>Estramustine (established)<\/li><li>Etanercept (established)<\/li><li>Etoposide (established)<\/li><li>Everolimus (theoretical)<\/li><li>Fingolimod (theoretical)<\/li><li>Floxuridine (established)<\/li><li>Fludarabine (established)<\/li><li>Fluorouracil (established)<\/li><li>Fotemustine (established)<\/li><li>Gallium Nitrate (established)<\/li><li>Gemcitabine (established)<\/li><li>Golimumab (theoretical)<\/li><li>Hydroxyurea (established)<\/li><li>Idarubicin (established)<\/li><li>Ifosfamide (established)<\/li><li>Immune Globulin (probable)<\/li><li>Infliximab (theoretical)<\/li><li>Irinotecan (established)<\/li><li>Lomustine (established)<\/li><li>Mechlorethamine (established)<\/li><li>Melphalan (established)<\/li><li>Mercaptopurine (established)<\/li><li>Methotrexate (established)<\/li><li>Mitolactol (established)<\/li><li>Mitomycin (established)<\/li><li>Mitotane (established)<\/li><li>Mitoxantrone (established)<\/li><li>Mycophenolic Acid (theoretical)<\/li><li>Oxaliplatin (established)<\/li><li>Paclitaxel (established)<\/li><li>Pegaspargase (established)<\/li><li>Pentostatin (established)<\/li><li>Pipobroman (established)<\/li><li>Pirarubicin (established)<\/li><li>Plicamycin (established)<\/li><li>Procarbazine (established)<\/li><li>Raltitrexed (established)<\/li><li>Rilonacept (theoretical)<\/li><li>Rituximab (established)<\/li><li>Secukinumab (theoretical)<\/li><li>Siltuximab (theoretical)<\/li><li>Sirolimus (probable)<\/li><li>Streptozocin (established)<\/li><li>Tacrolimus (theoretical)<\/li><li>Teceleukin (established)<\/li><li>Tegafur (established)<\/li><li>Temsirolimus (theoretical)<\/li><li>Teniposide (established)<\/li><li>Thioguanine (established)<\/li><li>Thiotepa (established)<\/li><li>Topotecan (established)<\/li><li>Trabectedin (theoretical)<\/li><li>Treosulfan (established)<\/li><li>Trimetrexate (established)<\/li><li>Trofosfamide (established)<\/li><li>Uracil Mustard (established)<\/li><li>Ustekinumab (theoretical)<\/li><li>Vinblastine (established)<\/li><li>Vincristine (established)<\/li><li>Vincristine Sulfate Liposome (established)<\/li><li>Vindesine (established)<\/li><li>Vinorelbine (established)<\/li><\/ul>"},"2":{"id":"jw2os4b15","title":"Moderate","mono":"<ul><li>Abatacept (probable)<\/li><li>Cytomegalovirus Immune Globulin, Human (probable)<\/li><li>Leflunomide (established)<\/li><li>Vaccinia Immune Globulin, Human (probable)<\/li><\/ul>"}}},"5":{"id":"jw2os5","title":"Adverse Effects","mono":"<b>Common<\/b><ul><li><b>Gastrointestinal:<\/b>Abdominal pain (6.4%), Nausea (5.8%)<\/li><li><b>Neurologic:<\/b>Headache (4.8%)<\/li><\/ul>"},"6":{"id":"jw2os6","title":"Drug Name Info","sub":{"0":{"id":"jw2os6b17","title":"US Trade Names","mono":"Vivotif<br\/>"},"2":{"id":"jw2os6b19","title":"Class","mono":"Vaccine<br\/>"},"3":{"id":"jw2os6b20","title":"Regulatory Status","mono":"RX<br\/>"}}},"7":{"id":"jw2os7","title":"Mechanism Of Action","mono":"Following the oral ingestion of live typhoid vaccine, which is an attenuated strain of Salmonella typhi TY21a (S. typhi), a quantity of complete lipopolysaccharide sufficient to generate a local protective immune response is synthesized in the intestinal tract, therefore preventing disease..<br\/>"},"8":{"id":"jw2os8","title":"Pharmacokinetics","sub":{"3":{"id":"jw2os8b26","title":"Excretion","mono":"Fecal <br\/>"}}},"9":{"id":"jw2os9","title":"Administration","mono":"<b>Oral<\/b><br\/><ul><li>administer capsule one hour before a meal with a cold or lukewarm drink (not to exceed body temperature) on alternate days (e.g., days 1, 3, 5, and 7)<\/li><li>capsules should not be chewed<\/li><li>complete immunization (ingestion of all 4 doses) should be completed at least one week prior to exposure<\/li><\/ul>"},"13":{"id":"jw2os13","title":"Clinical Teaching","mono":"<ul><li>This vaccine may cause abdominal pain, rash, diarrhea, nausea, vomiting, headache, or fever.<\/li><li>Advise patient to complete immunization dosing at least one week prior to potential exposure.<\/li><li>Instruct patient to take capsule 1 h prior to meals with cold or lukewarm drink.<\/li><li>Patient should call healthcare professional if a dose is missed, as vaccine should be given on a fixed schedule.<\/li><\/ul>"}}}